Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist “azaline B”-Reference-Cited by-同舟云学术

Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist “azaline B”

Published:1995-05 Issue:9 Volume:49 Page:1313-1321
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Campen Carolyn A.,Lai Muh-Tsann,Kraft Pat,Kirchner Tom,Phillips Audrey,Hahn Do Won,Rivier Jean

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference25 articles.

1. Chronic effects of [d-Trp6,Pro9-NEt]-luteinizing hormone releasing factor on reproductive processes in the male rat;Rivier;Endocrinology,1979

2. Pituitary gonadotropin inhibition by a highly active analog of luteinizing hormone-releasing hormone;Sandow;Fertil Steril,1978

3. The biochemistry, physiology, and pharmacology of gonadotropin releasing hormone (GnRH) and GnRH analogs;Friedman,1990

4. Use of a potent, long-acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty;Boepple;Endocr Rev,1986

5. Treatment of prostate cancer with gonadotropin-releasing hormone agonists;Labrie;Endocr Rev,1986

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of the gonadotrophin-releasing hormone antagonist azaline B to control the oestrous cycle in the koala (Phascolarctos cinereus);Reproduction, Fertility and Development;2016

2. Effect of azaline B on follicular development and functions in the hamster;Molecular and Cellular Endocrinology;2015-01

3. Hypothalamic gonadotropin-releasing hormone receptor activation stimulates oxytocin release from the rat hypothalamo-neurohypophysial system while melatonin inhibits this process;Brain Research Bulletin;2010-01

4. New Treatment Approaches for Prostate Cancer Based on Peptide Analogues;European Urology;2008-05

5. Gonadotropin-releasing-hormone-receptor antagonists;The Lancet;2001-11